| DOXGX | VEIRX | DOXGX / VEIRX | |
| Total Expense Ratio | 0.41 | 0.18 | 228% |
| Annual Report Gross Expense Ratio | 0.46 | 0.18 | 256% |
| Fund Existence | 4 years | 24 years | - |
| Gain YTD | 5.431 | 6.499 | 84% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 50000 | 5% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 119B | 63B | 189% |
| Annual Yield % from dividends | 1.41 | 2.20 | 64% |
| Returns for 1 year | 3.88 | 5.27 | 74% |
| Returns for 3 years | 30.34 | 10.51 | 289% |
| Returns for 5 years | N/A | 19.97 | - |
| Returns for 10 years | N/A | 49.21 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NVDX | 17.91 | 0.29 | +1.65% |
| T-REX 2X Long NVIDIA Daily Target ETF | |||
| BSMC | 35.25 | 0.06 | +0.17% |
| Brandes U.S. Small-Mid Cap Value ETF | |||
| FCTE | 25.40 | -0.02 | -0.08% |
| SMI 3Fourteen Full-Cycle Trend ETF | |||
| AQWA | 19.20 | -0.04 | -0.23% |
| Global X Clean Water ETF | |||
| XBI | 124.98 | -1.32 | -1.05% |
| State Street® SPDR® S&P® Biotech ETF | |||